Development and optimisation of mucoadhesive nanoparticles of acyclovir using design of experiments approach

References

• Alli SMA, Ali SMA, Fatmah K, Fatmah NY. Oral mucoadhesive microcarriers for controlled and extended release formulations. Int J Life Sci Pharm Res, 2011;1(1):41–59
   Google Scholar
• Ashwini RM, Mangesh RB, Rahul RP, Nilkanth SP, Devaki CU. Formulation and optimisation of drug-resin complex loaded mucoadhesive chitosan beads of repaglinide using factorial design. Am J Med Med Sci, 2012;2(4):62–70
   Google Scholar
• Attia IA, El-Gizawy SA, Fouda MA, Donia AM. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits. AAPS PharmSciTech, 2007;8(4):1022–8
   Google Scholar
• Bechgaard H, Ladefoged, K. Distribution of pellets in gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets. J Pharm Pharmacol, 1978;30(11):690–2
   PubMed Web of Science ®Google Scholar
• Bhandari R, Kaur IP. Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles. Int J Pharm, 2013;441(1–2):202–12
   PubMed Web of Science ®Google Scholar
• Chauhan B, Shimpi S, Mahadik K, Paradkar R. Preparation and evaluation of floating risedronate sodium Gelucire 39/01 matrices. Acta Pharm, 2004;54(3):205–14
   PubMedGoogle Scholar
• Coester CJ, Langer K, van Briesen H, Kreuter J. Gelatin nanoparticles by two step desolvation – A new preparation method, surface modifications and cell uptake. J Microencapsul, 2000;17(2):187–93
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 2001;13(2):123–33
   PubMed Web of Science ®Google Scholar
• Das S, Banerjee R, Bellare J. Aspirin loaded albumin nanoparticles by coacervation: Implications in drug delivery. Trends Biomater Artif Organs, 2005;18(2):203–11
   Google Scholar
• Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on release from controlled drug delivery system. Acta Pol Pharm, 2010;67(3):217–23
   PubMed Web of Science ®Google Scholar
• Dave BS, Amin AF, Patel MM. Gastroretentive drug delivery system of ranitidine hydrochloride: Formulation and in vitro evaluation. AAPS PharmSciTech, 2004;5(2):77–82
   Web of Science ®Google Scholar
• Desai S, Bolton S. A floating controlled-release drug delivery system: In vitro-in vivo evaluation. Pharm Res, 1993;10(9):1321–5
   PubMed Web of Science ®Google Scholar
• Deshpande AA, Shah NH, Rhodes CT, Mallick W. Development of a novel controlled release system for gastric retention. Pharm Res, 1997;14(6):815–19
   PubMed Web of Science ®Google Scholar
• Elshafeey AH, Kamel AO, Awad GA. Ammonium methacrylate units polymer content and their effect on acyclovir colloidal nanoparticles properties and bioavailability in human volunteers. Colloids Surf B Biointerfaces, 2010;75(2):398–404
   PubMed Web of Science ®Google Scholar
• Estudante M, Morias JG, Soveral G, Benet LZ. Intestinal drug transporters: An overview. Adv Drug Deliv Rev, 2013;65(10):1340–56
   PubMed Web of Science ®Google Scholar
• Ghosh PK, Majithiya RJ, Umrethia ML, Murthy RS. Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability. AAPS PharmSciTech, 2006;7(3):E1–6
   PubMedGoogle Scholar
• Gohel MC, Mehta PR, Dave RK, Bariya NH. A more relevant dissolution method for evaluation of floating drug delivery system. Disso Tech, 2004;11(4):22–5
   Google Scholar
• Groning R, Berntgen M, Geogarakis M. Acyclovir serum concentrations following per oral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit. Eur J Pharm Biopharm, 1996;46(3):285–91
   Web of Science ®Google Scholar
• Hao J, Wang F, Wang X, Zhang D, Bi Y, Gao Y, Zhao X, Zhang Q. Development and optimisation of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design. Eur J Pharm Sci, 2012;47(2):497–505
   PubMed Web of Science ®Google Scholar
• Herling AW. 2002. Activity on the gastrointestinal tract. In: Vogel WH, Scholkens BA, Snadow J, Muller G, Vogel WF, eds. Drug discovery and evaluation pharmacological assays. New York: Springer-Verlag Berlin Heidelberg, pp. 852–3
   Google Scholar
• ICH, International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Stability testing of new drug substances and products, Q1A (R2), Geneva, Switzerland, February 2003. Available at: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdf. Accessed 01 June 2013
   Google Scholar
• Irache JM, Huici M, Konecny M, Espuelas S, Campanero MA, Arbos P. Bioadhesive properties of Gantrez nanoparticles. Molecules, 2005;10(1):126–45
   PubMed Web of Science ®Google Scholar
• Jain R, Pandey A, Pandey SS. Mechanism of dissolution of delayed release formulation of diclofenac sodium. Chemistry, 2009;8(4):131–8
   Google Scholar
• Jain SK, Agrawal GP, Jain NK. A novel calcium silicate based microspheres of repaglinide: In vivo investigations. J Control Release, 2006;113(2):111–16
   PubMed Web of Science ®Google Scholar
• Jankowski A, Jankowska AL, Lamparczyk H. Determination and pharmacokinetics of acyclovir after ingestion of suspension form. J Pharm Biomed Anal, 1998;18(1–2):249–54
   PubMed Web of Science ®Google Scholar
• Kamel AO, Awad GA, Geneidi AS, Mortada ND. Preparation of intravenous stealthy acyclovir nanoparticles with increased mean residence time. AAPS PharmSciTech, 2009;10(4):1427–36
   PubMed Web of Science ®Google Scholar
• Kharia AA, Singhai AK. Screening of most effective variables for development of gastroretentive mucoadhesive nanoparticles by Taguchi design. ISRN Nanomaterials, 2013;2013:1–8
   Google Scholar
• Kharia AA, Singhai AK, Verma R. Formulation and evaluation of polymeric nanoparticles of an antiviral drug for gastroretention. Int J Pharm Sci Nanotech, 2012;4(4):1557–62
   Google Scholar
• Kharia AA, Hiremath SN, Singhai AK, Omray LK, Jain SK. Design and optimization of floating drug delivery system of acyclovir. Indian J Pharm Sci, 2010;72(5):599–606
   PubMed Web of Science ®Google Scholar
• Ma N, Xu L, Wang Q, Zhang X, Zhang W, Li Y, Jin L, Li S. Development and evaluation of new sustained release floating microspheres. Int J Pharm, 2008;358(1–2):82–90
   PubMed Web of Science ®Google Scholar
• Marty JJ, Oppenheim RC, Speiser P. Nanoparticles – A new colloidal drug delivery system. Pharm Acta Helv, 1978;53(1):17–23
   PubMedGoogle Scholar
• Meadows KC, Dressman JB. Mechanism of acyclovir uptake in rat jejunum. Pharm Res, 1990;7(3):299–303
   PubMed Web of Science ®Google Scholar
• Motwani SK, Chopra S, Talegaonkar S, Kohli K, Ahmad FJ, Khar RK. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimization and in vitro characterisation. Eur J Pharm Biopharm, 2008;68(3):513–25
   PubMed Web of Science ®Google Scholar
• Nahar M, Mishra D, Dubey V, Jain NK. Development, characterization and toxicity evaluation of amphotericin B loaded gelatin nanoparticles. Nanomedicine, 2008;4(3):252–61
   PubMed Web of Science ®Google Scholar
• Ofokansi K, Winter G, Fricker G, Coester C. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery. Eur J Pharm Biopharm, 2010;76(1):1–9
   PubMed Web of Science ®Google Scholar
• Park GB, Shao Z, Mitra AK. Acyclovir permeation enhancement across intestinal and nasal mucosae by bile salt–acylcarnitine mixed micelles. Pharm Res, 1992;9(10):1262–7
   PubMed Web of Science ®Google Scholar
• Ponchel G, Irache J. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev, 1998;34(2–3):191–219
   PubMed Web of Science ®Google Scholar
• Ramteke S, Maheshwari RBU, Jain NK. Clarithromycin based oral sustained release nanoparticulate drug delivery system. Indian J Pharm Sci, 2006;68(4):479–84
   Google Scholar
• Ravindran VK, Vasa S, Subadhra S, Banji D, Banji O, Rao M. Comparative study of mucoadhesive polymers carbopol 974P and sodium carboxy methyl cellulose for single unit dosage of imatinib mesylate. Malaysian J Pharm Sci, 2012;10(1):61–77
   Google Scholar
• Saphier S, Rosner A, Brandeis R, Karton Y. Gastro intestinal tracking and gastric emptying of solid dosage forms in rats using X-ray imagining. Int J Pharm, 2010;388(1–2):190–5
   PubMed Web of Science ®Google Scholar
• Saraogi GK, Gupta P, Gupta UD, Jain NK, Agrawal GP. Gelatin nanocarriers as potential vectors for effective management of tuberculosis. Int J Pharm, 2010;385(1–2):143–9
   PubMed Web of Science ®Google Scholar
• Schubert MA, Muller-Goymann CC. Solvent injection as a new approach for manufacturing lipid nanoparticles-evaluation of the method and process parameters. Eur J Pharm Biopharm, 2003;55(1):125–31
   PubMed Web of Science ®Google Scholar
• Schwartz JB, O'Connor RE, Schnaare RL. 2009. Optimization techniques in pharmaceutical formulation and processing. In: Banker GS, Rhodes CT, eds. Modern pharmaceutics. New York: Informa Healthcare, pp. 607–26
   Google Scholar
• Sharma M, Nautiyal P, Jain S, Jain D. Simple and rapid RP-HPLC method for simultaneous determination of acyclovir and zidovudine in human plasma. J AOAC Int, 2010;93(5):1462–7
   PubMed Web of Science ®Google Scholar
• Singh B, Chakkal SK, Ahuja N. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS PharmSciTech, 2006;7(1):E1–10
   PubMed Web of Science ®Google Scholar
• Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using “Design of Experiments” Part I: Fundamental aspects. Crit Rev Ther Drug Carrier Syst 2005;22(1):27–105
   PubMed Web of Science ®Google Scholar
• Singh B, Pahuja S, Kapil R, Ahuja N. Formulation development of oral controlled release tablets of hydralazine: Optimization of drug release and bioadhesive characteristics. Acta Pharm, 2009;59(1):1–13
   PubMed Web of Science ®Google Scholar
• Tao Y, Lu Y, Sun Y, Gu B, Lu W, Pan J. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability. Int J Pharm, 2009;378(1–2):30–6
   PubMed Web of Science ®Google Scholar
• Thahera PD, Latha AK, Shailaja T, Nyamathulla S, Uhunwangho MU. Formulation and evaluation of norfloxacin gastroretentive drug delivery systems using natural polmers. Int Curr Pharm J, 2012;1(7):155–64
   Google Scholar
• Thirawong N, Nunthanid J, Puttipipatkhachorn S, Sriamornsak P. Mucoadhesive properties of various pectins on gastrointestinal mucosa: An in vitro evaluation using texture analyzer. Eur J Pharm Biopharm, 2007;67(1):132–40
   PubMed Web of Science ®Google Scholar
• Xu X, Khan MA, Burgess, DJ. A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale. Int J Pharm, 2012;423(2):543–53
   PubMed Web of Science ®Google Scholar
• Yuce M, Canefe K. Indomethacin loaded microspheres: Preparation, characterization and in vitro evaluation regarding ethyl cellulose matrix material. Tur J Pharm Sci, 2008;5(3):129–42
   Google Scholar
• Zhang Y, Huo M, Zhou J, Xie S. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed, 2010;99(3):306–14
   PubMed Web of Science ®Google Scholar